J. Pillot

L. Bélec, J. Pillot, N. Cancré, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Identification of a strong enhancer element upstream from the pregenomic RNA start site of the duck hepatitis B virus genome

M. Levrero, J. Pillot, A. Lilienbaum, 1991, Journal of virology.

Identification ofa Strong Enhancer ElementUpstream fromthe Pregenomic RNA Start SiteoftheDuckHepatitis B VirusGenome

M. Levrero, J. Pillot, A. Lilienbaum, 1991 .

Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine.

A. Budkowska, T. Poynard, J. Pillot, 1995, Vaccine.

[Structure of spirochetes. 1. Study of the genera Treponema, Borrelia and Leptospira by the electron microscope].

A. Ryter, J. Pillot, 1965, Annales de l'Institut Pasteur.

Human Seminal Plasma Suppresses the Chemiluminescence of Polymorphonuclears Without Modifying Phagocytosis

J. Bouvet, J. Pillot, L. Lebrun, 1990, American journal of reproductive immunology.

Human Fc(gamma) receptors for differentiation in throat cultures of group C "Streptococcus equisimilis" and group C "Streptococcus milleri"

P. Wallet, M. Guibert, J. Pillot, 1986, Journal of clinical microbiology.

Human secretory component-I. Evidence for a new antigenic specificity.

J. Pillot, S. Iscaki, C. Geneste, 1978, Immunochemistry.

ELISA in serodiagnosis of HCV infection.

J. Pillot, Y. Lazizi, M. Rioche, 1994, FEMS microbiology reviews.

Detection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reaction

J. Pillot, Y. Lazizi, E. Elfassi, 1992, Journal of clinical microbiology.

High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.

M. Bomsel, H. Hocini, L. Bélec, 1997, AIDS research and human retroviruses.

Systemic and Secretory Humoral Immunity in the Normal Human Vaginal Tract

H. Hocini, L. Bélec, J. Bouvet, 1995, Scandinavian journal of immunology.

HEPATITIS B VACCINE: A DIAGNOSTIC TEST FOR PREVIOUS HEPATITIS B VIRUS INFECTION?

T. Poynard, S. Naveau, J. Pillot, 1984, The Lancet.

[Primates in the study of hepatitis viruses].

J. Pillot, 1990, Pathologie-biologie.

Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation.

F. Sztark, S. Roullet, G. Freyburger, 2010, British journal of anaesthesia.

Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays

L. Bélec, A. Georges, C. Tevi-Benissan, 1995, Clinical and diagnostic laboratory immunology.

Polymerase chain reaction to monitor repair of the HBV genome, the first step in viral replication.

P. Maillard, J. Pillot, 1996, Research in virology.

PRENATAL DIAGNOSIS OF CONGENITAL RUBELLA

F. Daffos, F. Forestier, J. Pillot, 1984, The Lancet.

Protection by Human Serum from the Immunosuppression Induced by Spermine in Vitro

J. Bouvet, J. Pillot, C. Quan, 1991, American journal of reproductive immunology.

Serial passage of West‐European sporadic non‐A non‐B hepatitis in rhesus monkeys by inoculation with fecal extracts

G. P. Talwar, P. Maillard, T. Poynard, 1990, Journal of medical virology.

Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations

J. Fournier, J. Pillot, M. Riottot, 1979, Infection and immunity.

Vaccination Against Hepatitis B Virus: Past and Future Problems

J. Pillot, 1983 .

Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles.

M. Petit, J. Pillot, F. Capel, 1985, Molecular immunology.

HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells

M. Petit, J. Pillot, 1985, Journal of virology.

Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting.

M. Petit, J. Pillot, 1984, Molecular immunology.

Detection of antibodies directed against the pre-S gene product of hepatitis B virus: relationship between anti-pre-S response and recovery.

A. Budkowska, J. Pillot, P. Dubreuil, 1985, Annales de l'Institut Pasteur. Immunologie.

Antigenic mapping of the surface proteins of infectious hepatitis B virus particles.

C. Dauguet, M. Petit, J. Pillot, 1987, The Journal of general virology.

Optimal conditions for elution of hepatitis B antigen after absorption onto colloidal silica

J. Pillot, R. Keros, S. Goueffon, 1976, Journal of clinical microbiology.

Interplay between a new HNF3 and the HNF1 transcriptional factors in the duck hepatitis B virus enhancer.

J. Pillot, A. Lilienbaum, B. Crescenzo-Chaigne, 1995, Virology.

Binding of nuclear factors to functional domains of the duck hepatitis B virus enhancer

A. Sall, J. Pillot, A. Lilienbaum, 1993, Journal of virology.

Monoclonal Antibody Recognizing Pre‐S(2) Epitope of Hepatitis B Virus: Characterization of Pre‐S(2) Epitope and Anti‐Pre‐S(2) Antibody

C. Bréchot, A. Budkowska, M. Petit, 1986, Journal of medical virology.

990 HEPATITIS B VIRUS TYPE 2

A. Budkowska, J. Pillot, Antoine Ouattara, 2003 .

HEPATITIS B VIRUS TYPE 2

Y. Ko, A. Budkowska, Wu-Tse Liu, 1988, The Lancet.

ANTI-PRE-S2 AS ONLY SERUM HBV MARKER: POSSIBLE RELATION TO HBV-2 INFECTION

A. Budkowska, J. Pillot, P. Dubreuil, 1988, The Lancet.

Delayed clearance of HBV‐DNA detected by PCR in the absence of viral replication

J. Pillot, Y. Lazizi, 1993, Journal of medical virology.

REACTIVATION OF HEPATITIS B

J. Pillot, Y. Lazizi, L. Grangeot‐Keros, 1989, The Lancet.

Detection of antibodies to pre-S2 encoded epitopes of hepatitis B virus by monoclonal antibody-enzyme immunoassay.

A. Budkowska, J. Pillot, P. Dubreuil, 1987, Journal of immunological methods.

A monoclonal antibody enzyme immunoassay for the detection of epitopes encoded by the pre-S2 region of the hepatitis B virus genome.

A. Budkowska, J. Pillot, P. Dubreuil, 1987, Journal of immunological methods.

Liver hepatitis B e antigen: Molecular heterogeneity and relation to hepatitis B virus core antigen

A. Budkowska, M. Petit, J. Pillot, 1986 .

Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.

P. Maillard, M. Petit, J. Pillot, 1986, Molecular immunology.

Prognostic significance of pre-S2 antigen and antibody in fulminant hepatitis B. Evidence for heterogeneous serological responses.

R. Williams, A. Budkowska, J. Pillot, 1991, Journal of hepatology.

A biphasic pattern of anti‐pre‐s responses in acute hepatitis B virus infection

P. Maillard, A. Budkowska, T. Poynard, 1990, Hepatology.

Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype.

J. Delfraissy, J. Pillot, M. Rannou, 1994, Research in virology.

HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination.

P. Debré, A. Budkowska, J. Pillot, 1989, Tissue antigens.

Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA.

S. Badur, J. Pillot, Y. Lazizi, 1997, Vaccine.

Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns.

S. Badur, J. Pillot, Y. Lazizi, 1994, The Journal of infectious diseases.

Anti—pre‐S responses and viral clearance in chronic hepatitis B virus infection

M. Loriot, P. Marcellin, P. Maillard, 1992, Hepatology.

At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis.

P. Maillard, J. Pillot, 1998, Research in virology.

Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of HBV DNA

S. Badur, J. Pillot, Y. Lazizi, 1997 .

Anti-hepatitis E virus markers in hemodialysis patients.

G. Jahn, J. Pillot, B. Flehmig, 1996, Nephron.

A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E

J. Meng, J. Pillot, P. Dubreuil, 1997, Journal of clinical microbiology.

Molecular analysis of the modulatory factors of the response to HBsAg in mice as an approach to HBV vaccine enhancement.

J. Pillot, A. Cosson, S. Iscaki, 1996, FEMS immunology and medical microbiology.

Occurrence of pre‐S1 antigen in viremic and nonviremic carriers of hepatitis B surface antigen

J. Pillot, P. Dubreuil, Y. Lazizi, 1988, Journal of medical virology.

Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.

S. Kent, A. Budkowska, A. Neurath, 1987, Molecular immunology.

Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain

A. Louise, A. Budkowska, J. Pillot, 1995, Journal of virology.

[Transmission of hepatitis B virus from mother to child in Bamako-Mali].

J. Pillot, Y. Maiga, M. Marjolet, 1992, Bulletin de la Societe de pathologie exotique.

Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection

A. Budkowska, J. Pillot, P. Dubreuil, 1989 .

Prognostic value of HBsAg/IgM complexes in hepatitis B patients: Nature of the proteins involved

J. Pillot, G. Pelletier, M. Briantais, 1988, Journal of medical virology.

The year of Pasteur: from the concept of antibody and antigen by Bordet (1895) to the ELISA. What future for immunological diagnosis?

J. Pillot, 1996, Clinical and diagnostic virology.

HBsAg in urine: a new approach for the detection of urinary antigens

S. Badur, J. Pillot, L. Grangeot‐Keros, 1992, Clinical and experimental immunology.

Heterogeneity of the HBe antigen-antibody system in human patients: Distribution and partial purification of the prevalent specificity (HBe1)

J. Pillot, F. Capel, 1980 .

Serumandintestinal secretory IgAinalcoholic cirrhosis oftheliver

J. Pillot, G. Pelletier, C. Buffet, 1982 .

Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.

L. Bélec, J. Pillot, Xuezhao Lu, 1993, The Journal of infectious diseases.

Human secretory component. IV: Antigenic regions involved in in vitro binding to dimeric IgA.

J. Pillot, S. Iscaki, C. Geneste, 1986, Immunology letters.

A modified gel filtration technique producing an unusual exclusion volume of IgM: a simple way of preparing monoclonal IgM.

J. Bouvet, J. Pillot, R. Pirès, 1984, Journal of immunological methods.

Significance of anti-IgG antibodies obtained by immunization of rabbits with some streptococcal strains.

J. Pillot, L. Lebrun, L. Grangeot‐Keros, 1982, Annales d'immunologie.

Purification and partial amino acid sequence of suppressive lymphokine from a CD8+ CD57+ human T hybridoma.

S. Watanabe, F. Vuillier, J. Bouvet, 1993, Immunology.

The Antigenic Constitution of Treponema. I. The Protein Antigen of Reìter's Strain.

J. Pillot, M. Faure, 1959 .

CHARACTERIZATION OF THE MYCOPLASMA‐LIKE ORGANISM ASSOCIATED WITH “STUBBORN” DISEASE OF CITRUS

D. Taylor-Robinson, P. Saglio, J. Tully, 1973 .

In vivo and in vitro immunosuppressions in mice by a 100-110-Kd fraction from boar seminal plasma.

J. Bouvet, J. Pillot, J. Couderc, 1987, American journal of reproductive immunology and microbiology : AJRIM.

Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: Possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim

L. Bélec, C. Tevi-Benissan, J. Pillot, 1995, Journal of medical virology.

Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse

L. Bélec, G. Grésenguet, J. Pillot, 1994, Journal of clinical microbiology.

HIV-1 antibody serum negativity with vaginal secretions positivity

L. Bélec, G. Grésenguet, C. Tevi-Benissan, 1994, The Lancet.

Enhanced local immunity in vaginal secretions of HIV-infected women

L. Bélec, J. Pillot, P. Martin, 1991, The Lancet.

Human immunodeficiency virus type 1 p24 antigen in cervicovaginal secretions.

L. Bélec, G. Grésenguet, C. Tevi-Benissan, 1995, The Journal of infectious diseases.

Prenatal and postnatal production of IgM and IgA antibodies to rubella virus studied by antibody capture immunoassay.

F. Daffos, F. Forestier, J. Pillot, 1988, The Journal of infectious diseases.

Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination

L. Bélec, J. Bouvet, J. Pillot, 1994, Infection and immunity.

Delineation between T- and B-suppressive molecules from human seminal plasma: I. Partial characterization of a 180-kD protein inhibiting the B response to T-independent antigens.

J. Bouvet, J. Pillot, J. Couderc, 1988, American journal of reproductive immunology and microbiology : AJRIM.

FALSE-POSITIVE IgM ANTI-TOXOPLASMA FLUORESCENT TEST DUE TO RHEUMATOID FACTOR

P. Yeni, P. Massias, J. Pillot, 1978, The Lancet.

IgM reassociation in the absence of J-chain.

J. Bouvet, J. Pillot, S. Iscaki, 1987, Immunology letters.

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus.

J. Meng, J. Chang, Y. Khudyakov, 2001, Virology.

Secretory Component‐Binding Properties of Normal Serum IgM

J. Bouvet, J. Pillot, S. Iscaki, 1990, Scandinavian journal of immunology.

Three M-components IgA lambda + IgG kappa n + IgG kappa h in one patient (DA): lack of shared idiotypic determinants between IgA and IgG, and the presence of an unusual kappa h chain of 30,000 M.W.

J. Bouvet, A. Wang, J. Pillot, 1980, Journal of immunology.

M2 alpha-1-antitrypsin phenotype and primary liver cancer.

J. Estève, R. Frants, M. Clerc, 1981, British Journal of Cancer.

Characterization of an antigen-antibody system associated with epidemic non-A,non-B hepatitis in west africa and experimental transmission of an infectious agent to primates

A. Budkowska, J. Sarthou, J. Pillot, 1986 .

Frequent sporadic hepatitis E in west Africa evidenced by characterization of a virus-associated antigen in the stool.

B. Leguenno, J. Pillot, Y. Lazizi, 1992, Journal of hepatology.

Hepatitis-E-virus-associated antigen: improved detection in stools by protein Fv removal.

J. Pillot, B. Le Guenno, Y. Lazizi, 1991, Research in virology.

Immunological characterization of a viral agent involved in epidemic and sporadic non-A,non-B hepatitis

C. Dauguet, A. Budkowska, J. Sarthou, 1987 .

Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS

L. Bélec, T. Prazuck, J. Pillot, 1995, Clinical and experimental immunology.

Detection of human Fc (gamma) receptors on streptococci by indirect immunofluorescence staining: a survey of streptococci freshly isolated from patients

J. Pillot, L. Lebrun, M. Rannou, 1982, Journal of clinical microbiology.

Non‐Immune Binding of Human Protein Fv to Immunoglobulins from Various Mammalian and Non‐Mammalian Species

J. Bouvet, J. Pillot, J. Charlemagne, 1991, Scandinavian journal of immunology.

Rubella reinfection and the fetus.

J. Nicolas, J. Pillot, F. Bricout, 1985, The New England journal of medicine.

Use of in vivo challenge to assess rubella immunity determined by haemagglutination inhibition and latex agglutination.

S. Badur, J. Pillot, L. Grangeot‐Keros, 1989, Research in virology.

Primary structure of open reading frame 2 and 3 of the hepatitis E virus isolated from Morocco

J. Meng, M. Purdy, Y. Khudyakov, 1999, Journal of medical virology.

Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources.

J. Meng, Y. Khudyakov, J. Pillot, 1998, Virology.

African strains of hepatitis E virus that are distinct from Asian strains

P. Coursaget, S. Emerson, R. Purcell, 1997, Journal of medical virology.

Interest of immunomodulation as a mean to improve the preparation of polyclonal and monoclonal antibody reagents.

A. Budkowska, J. Pillot, A. Cosson, 1997, Journal of immunological methods.

[Incidence of sporadic hepatitis E in Ivory Coast based on still problematic serology].

P. Nordmann, J. Pillot, P. Dubreuil, 1997, Bulletin of the World Health Organization.

Specificity and sensitivity of the IgM capture immunoassay: studies of possible factors inducing false positive or false negative results.

J. Pillot, M. Briantais, L. Grangeot‐Keros, 1984, Journal of virological methods.

Nonimmune macromolecular complexes of Ig in human gut lumen. Probable enhancement of antibody functions.

J. Bouvet, J. Pillot, S. Iscaki, 1993, Journal of immunology.

A new simple blot transfer method following cellogel electrophoresis which preserves antibody activity: application to the analysis of monoclonal and oligoclonal fluids.

J. Bouvet, J. Pillot, 1985, Annales de l'Institut Pasteur. Immunologie.

Antibodies to HTLV-I in Sjögren's syndrome

X. Mariette, L. Bélec, D. Cazals, 1995, The Lancet.

Cervicovaginal anti-HIV antibodies in index women from HIV-discordant, exclusively heterosexual, couples.

H. Hocini, L. Bélec, J. Malkin, 1996, Viral immunology.

CONSIDERATIONS ON THE PRACTICAL EFFECTS OF LUBRICANTS AND BINDERS COMMONLY USED IN COMPACTING METAL POWDERS

J. Pillot, H. Pastor, R. Meyer, 1969 .

Detection of Legionella pneumophila antigen by ELISA in urine or experimentally infected guinea-pigs.

C. Tram, F. Lapierre, J. Pillot, 1983, Annales de microbiologie.

Non‐immune VH‐binding Specificity of Human Protein Fv

J. Bouvet, J. Pillot, C. Quan, 1991, Scandinavian journal of immunology.

Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis.

D. Valla, P. Maillard, J. Bouvet, 1990, Journal of immunology.

[Prevalence of serum anti-hepatitis C virus antibodies and risk factors of contamination in the personnel of a hospital in the Paris region. A prospective survey].

T. Poynard, M. Maillard, J. Pillot, 1996, Gastroenterologie clinique et biologique.

[Trial of hepatitis B prophylaxis in children born to mothers carrying HBs antigen in New Caledonia].

J. Pillot, M. Laille, J. Moreau, 1988, Bulletin de la Societe de pathologie exotique et de ses filiales.

An indirect immunofluorescence staining procedure for detection of human Fc gamma receptors on streptococci.

J. Pillot, L. Lebrun, L. Grangeot‐Keros, 1982, Journal of immunological methods.

Excess HBcAg in HBc antibody–negative chronic hepatitis B virus carriers

J. Pillot, P. Dubreuil, Y. Lazizi, 1993, Hepatology.